Please log in to determine if you are eligible to purchase PT Programs.
MULTIGENE TUMOR PANEL - MTP
MTP
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte Challenges per Shipment Number of Shipments
BRAF 3 Two shipments per year
EGFR 3
HER2 (ERBB2) 3
KIT 3
KRAS 3
NRAS 3
PDGFRA 3
PIK3CA 3

Additional Information

    BRAF, EGFR, and KRAS are required analytes. Laboratories that perform testing for the detection of somatic single nucleotide variants, insertions, and deletions in these genes are required to enroll in either MTP or the respective single gene Surveys. This includes laboratories that perform NGS-based assays, non-NGS-based multiplexed assays, and nonmultiplexed assays (eg, Sanger sequencing). Laboratories that perform NGS-based testing are encouraged to also enroll in NGSST, as this proficiency testing program provides challenges with lower variant allele fractions as well as challenges in other genes commonly included in NGS-based panels for the identification of somatic variants in solid tumors.

Program Information

  • Three 2.0‑μg gDNA (50ng/‑μL) specimens for laboratories performing molecular testing on multiple targets

Shipping Schedule

  • Shipment A: April 29
  • Shipment B: October 28






Customers Who Bought This Item Also Bought
CELL-FREE TUMOR DNA
VIEW DETAILS >